• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国北部地区针对感染艾滋病毒者实施异烟肼潜伏性结核感染治疗方案的障碍与动机

Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.

作者信息

Moolphate Saiyud, Lawpoolsri Saranath, Pungrassami Petchawan, Sanguanwongse Natpatou, Yamada Norio, Kaewkungwal Jaranit

机构信息

Department of Tropical Hygiene, Mahidol University, Japan.

出版信息

Glob J Health Sci. 2013 Mar 25;5(4):60-70. doi: 10.5539/gjhs.v5n4p60.

DOI:10.5539/gjhs.v5n4p60
PMID:23777722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4776827/
Abstract

BACKGROUND

Isoniazid Preventive Therapy (IPT) has been recommended by WHO/UNAIDS for people living with HIV (PLWH) since 1993; however the uptake of IPT implementation has been very low globally. This study aims to assess the barriers to and motivations for the implementation of IPT for PLWH in upper northern Thailand, an area with a high tuberculosis (TB) and human immunodeficiency virus (HIV) burden.

METHODS

A survey was carried out via self-administered questionnaires mailed to healthcare workers (HCW) in all 95 public hospitals in the upper northern region of Thailand. A reminding phone call, one month after sending the mail, was made.

RESULTS

The response rate from the hospitals was 94% and from the HCW's, 70%. IPT programme was being implemented at only 18 (20%) out of the 89 public hospitals. The main barriers as reported by 144 HCWs working in hospitals without IPT programme, were: (1) unclear direction of national policy (60%), (2) fear of emerging Isoniazid resistant tuberculosis (52%), and (3) fear of poor adherence (30%). The 38 HCWs from hospitals implementing IPT programme, were motivated by (1) knowledge that IPT can prevent TB (63%), (2) the following of national guideline (34%), (3) concern for TB prevention even after the expansion of access to antiretroviral therapy (ART) (32%).

CONCLUSION AND RECOMMENDATION

To implement an IPT programme for PLWH, giving a clear national policy and straightforward direction are necessary. Furthermore, provision of public health information and updated evidences may enhance HCW's comprehension of benefits and risks of IPT, thus it may increase the IPT programme implementation.

摘要

背景

自1993年以来,世界卫生组织/联合国艾滋病规划署已建议对艾滋病毒感染者(PLWH)采用异烟肼预防性治疗(IPT);然而,IPT实施的全球覆盖率一直很低。本研究旨在评估泰国北部地区实施PLWH的IPT的障碍和动机,该地区结核病(TB)和人类免疫缺陷病毒(HIV)负担较高。

方法

通过向泰国北部地区所有95家公立医院的医护人员(HCW)邮寄自填问卷进行调查。邮件发出一个月后进行了提醒电话。

结果

医院的回复率为94%,医护人员的回复率为70%。在89家公立医院中,只有18家(20%)实施了IPT项目。在没有IPT项目的医院工作的144名医护人员报告的主要障碍是:(1)国家政策方向不明确(60%),(2)担心出现异烟肼耐药结核病(52%),以及(3)担心依从性差(30%)。来自实施IPT项目医院的38名医护人员的动机是:(1)知道IPT可以预防结核病(63%),(2)遵循国家指南(34%),(3)即使在扩大抗逆转录病毒治疗(ART)可及性之后仍关注结核病预防(32%)。

结论与建议

要为PLWH实施IPT项目,明确的国家政策和直接的指导是必要的。此外,提供公共卫生信息和最新证据可能会增强医护人员对IPT益处和风险的理解,从而可能增加IPT项目的实施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d4/4776827/cd7236daed6c/GJHS-5-60-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d4/4776827/cd7236daed6c/GJHS-5-60-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6d4/4776827/cd7236daed6c/GJHS-5-60-g001.jpg

相似文献

1
Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.泰国北部地区针对感染艾滋病毒者实施异烟肼潜伏性结核感染治疗方案的障碍与动机
Glob J Health Sci. 2013 Mar 25;5(4):60-70. doi: 10.5539/gjhs.v5n4p60.
2
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.异烟肼预防性治疗结局的前瞻性队列研究:乌干达一项全国性质量改进协作项目中的嵌套研究
AIDS Res Ther. 2020 May 27;17(1):28. doi: 10.1186/s12981-020-00285-0.
3
Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.肯尼亚国家转诊医院中影响 HIV 感染儿童使用异烟肼预防性治疗的因素:一项混合定量和定性研究。
BMC Infect Dis. 2020 Apr 21;20(1):294. doi: 10.1186/s12879-020-05011-9.
4
Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.在泰国为艾滋病毒感染者实施异烟肼预防性治疗项目。
PLoS One. 2017 Sep 26;12(9):e0184986. doi: 10.1371/journal.pone.0184986. eCollection 2017.
5
Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria.在尼日利亚西南部拉各斯的一家三级医疗机构就诊的 HIV 感染患者中,异烟肼预防治疗的采用率较低。
Pan Afr Med J. 2021 Jun 13;39:123. doi: 10.11604/pamj.2021.39.123.28095. eCollection 2021.
6
Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.坦桑尼亚达累斯萨拉姆对临床筛查潜伏性结核感染的艾滋病毒感染者进行异烟肼预防性治疗的成本效益:一项前瞻性队列研究。
BMC Public Health. 2017 Jul 19;18(1):35. doi: 10.1186/s12889-017-4597-9.
7
Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.异烟肼预防性治疗对降低埃塞俄比亚亚的斯亚贝巴公共卫生设施中艾滋病毒/艾滋病感染者活动性结核病发病率的有效性:一项历史性队列研究。
BMC Infect Dis. 2017 Jan 3;17(1):5. doi: 10.1186/s12879-016-2109-7.
8
Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.在尼日利亚东南部的多层次卫生机构中,艾滋病毒感染者对异烟肼预防性治疗的认知和坚持情况:一项准实验研究的基线结果。
Pan Afr Med J. 2020 Aug 10;36:261. doi: 10.11604/pamj.2020.36.261.22496. eCollection 2020.
9
Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: a qualitative study.肯尼亚内罗毕县部分艾滋病诊所医护人员中影响异烟肼预防性治疗可接受性的因素:一项定性研究
BMJ Open. 2018 Dec 19;8(12):e024286. doi: 10.1136/bmjopen-2018-024286.
10
Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience.实施与运营研究:在乌干达实施世界卫生组织2011年针对感染艾滋病毒/艾滋病儿童的异烟肼预防性治疗(IPT)建议的经验。
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):e1-8. doi: 10.1097/QAI.0000000000000806.

引用本文的文献

1
How can we improve latent tuberculosis infection management using behaviour change wheel: a systematic review.如何利用行为改变轮改进潜伏性结核感染管理:系统评价。
J Public Health (Oxf). 2023 Aug 28;45(3):e447-e466. doi: 10.1093/pubmed/fdad051.
2
Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project.将异烟肼预防性治疗纳入赞比亚城市地区的快速艾滋病毒治疗模式:一项概念验证试点项目。
PLOS Glob Public Health. 2023 Mar 8;3(3):e0000909. doi: 10.1371/journal.pgph.0000909. eCollection 2023.
3
Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria.

本文引用的文献

1
Global evidence directing regional preventive strategies in Southeast Asia for fighting TB/HIV.指导东南亚地区抗击结核病/艾滋病预防策略的全球证据。
J Infect Dev Ctries. 2013 Mar 14;7(3):191-202. doi: 10.3855/jidc.2903.
2
Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand.泰国北部清莱结核病与艾滋病毒合并感染患者的死亡原因
HIV AIDS (Auckl). 2012;4:159-68. doi: 10.2147/HIV.S33535. Epub 2012 Oct 4.
3
Survey of isoniazid preventive therapy in South Africa, 2011.2011 年南非异烟肼预防治疗调查。
在尼日利亚西南部拉各斯的一家三级医疗机构就诊的 HIV 感染患者中,异烟肼预防治疗的采用率较低。
Pan Afr Med J. 2021 Jun 13;39:123. doi: 10.11604/pamj.2021.39.123.28095. eCollection 2021.
4
Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting.方案环境中,异烟肼预防治疗对 HIV 感染成人结核病发病率的影响。
Indian J Med Res. 2020 Dec;152(6):648-655. doi: 10.4103/ijmr.IJMR_1582_18.
5
Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa.在南非农村地区基层医疗诊所实施推荐的结核病预防性治疗的结构障碍。
Glob Public Health. 2022 Apr;17(4):555-568. doi: 10.1080/17441692.2021.1892793. Epub 2021 Mar 2.
6
Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.在坦桑尼亚的一家儿科艾滋病毒诊所成功实施异烟肼预防治疗。
BMC Infect Dis. 2020 Oct 7;20(1):738. doi: 10.1186/s12879-020-05471-z.
7
Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria.采用质量改进方法提高符合条件的艾滋病毒患者中异烟肼预防性治疗的覆盖率和完成率:尼日利亚奥贡州伊杰布奥德州立医院的案例研究
Pan Afr Med J. 2019 Dec 11;34:193. doi: 10.11604/pamj.2019.34.193.19360. eCollection 2019.
8
..
Int J Tuberc Lung Dis. 2019 Mar 1;23(3):371-377. doi: 10.5588/ijtld.18.0378.
9
Breakthrough tuberculosis disease among people with HIV - Should we be worried? A retrospective longitudinal study.HIV 感染者中的突破性结核病 - 我们是否应该担心?一项回顾性纵向研究。
PLoS One. 2019 Feb 4;14(2):e0211688. doi: 10.1371/journal.pone.0211688. eCollection 2019.
10
Increasing isoniazid preventive therapy uptake in an HIV program in rural Papua New Guinea.在巴布亚新几内亚农村地区的一个艾滋病项目中提高异烟肼预防性治疗的使用率。
Public Health Action. 2017 Sep 21;7(3):193-198. doi: 10.5588/pha.17.0011.
Int J Tuberc Lung Dis. 2012 Jul;16(7):903-7. doi: 10.5588/ijtld.11.0722. Epub 2012 May 7.
4
Time of highest tuberculosis death risk and associated factors: an observation of 12 years in Northern Thailand.时间最高结核病死亡风险及相关因素:在泰国北部的 12 年观察。
Int J Gen Med. 2011 Feb 28;4:181-90. doi: 10.2147/IJGM.S16486.
5
Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment.HIV 感染者的结核病死亡率:跨国系统评估。
Clin Epidemiol. 2011 Jan 19;3:21-9. doi: 10.2147/CLEP.S15574.
6
The effect of tuberculosis on mortality in HIV positive people: a meta-analysis.结核病对 HIV 阳性人群死亡率的影响:一项荟萃分析。
PLoS One. 2010 Dec 30;5(12):e15241. doi: 10.1371/journal.pone.0015241.
7
Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions.全球范围内为艾滋病毒感染者实施异烟肼预防性治疗:障碍与解决方案
AIDS. 2010 Nov;24 Suppl 5:S57-65. doi: 10.1097/01.aids.0000391023.03037.1f.
8
Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.在工作场所方案中,抗逆转录病毒治疗个体接受异烟肼预防治疗与早期死亡率降低相关。
AIDS. 2010 Nov;24 Suppl 5(0 5):S5-13. doi: 10.1097/01.aids.0000391010.02774.6f.
9
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.在 HIV 诊所中实施异烟肼预防治疗的障碍:一项定性研究。
AIDS. 2010 Nov;24 Suppl 5:S45-8. doi: 10.1097/01.aids.0000391021.18284.12.
10
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.复方磺胺甲噁唑预防用药和异烟肼预防治疗在 HIV 感染者中的实施。
Bull World Health Organ. 2010 Apr;88(4):253-9. doi: 10.2471/BLT.09.066522. Epub 2009 Oct 23.